首頁 > 市場調查報告書 > 工業機械

市場調查報告書

商品編碼

1618410

生物安全櫃市場：按產品類型、最終用戶和地區劃分，2024-2031 年

Biological Safety Cabinets Market By Product Type, End-User, & Region for 2024-2031

出版日期: 2024年07月19日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

生物安全櫃市場評估，2024-2031

人們越來越重視實驗室安全以及管理研究和臨床環境的嚴格法規。隨著生物製藥研究的增加，特別是在藥物開發、疫苗生產和先進治療方面，對保護人員和研究材料免受污染的受控環境的需求不斷增加。醫療基礎設施的不斷擴張，尤其是新興市場的醫療基礎設施的不斷擴張，也推動了市場的成長，更多的實驗室和醫療設施正在建設中，推動市場增長到2024年和2031年將突破2.0496億美元，預計將達到3.285億美元到2020年。

此外，COVID-19 大流行凸顯了生物安全的重要性，促使對高品質安全櫃的投資增加，以確保病原體遏制和遵守安全協議。因此，由於這些關鍵因素，預計 2024 年至 2031 年市場將以約 6.70% 的複合年增長率成長。

生物安全櫃市場定義/概述

生物安全櫃 (BSC) 是一個封閉、通風的實驗室空間，旨在保護使用者、環境和研究材料免受有害病原體和污染物的侵害。它通常用於需要處理傳染性或危險材料的領域，例如微生物學、病毒學、生物製藥研究和臨床診斷。BSC 的未來充滿希望，由於生物製藥行業的擴張、對實驗室安全的日益重視以及全球監管標準的不斷提高，BSC 的採用率不斷提高。隨著生物技術和醫療保健的進步，對更先進和客製化平衡計分卡的需求預計將會增加，特別是隨著提高安全性和效率的智慧技術的結合。

藥物開發和疫苗製造的進步會擴大生物安全櫃市場嗎？

藥物開發和疫苗製造的進步預計將顯著擴大生物安全櫃（BSC）的市場。隨著製藥業開發新的藥物療法和疫苗技術，對高品質生物安全櫃的需求不斷增加，為研究、開發和生產過程提供無菌和安全的環境。現代藥物開發和疫苗生產複雜且大規模，需要先進的平衡計分卡來保護研究人員和產品免受污染，而這些櫃子的設計對於維持實驗室嚴格的安全標準至關重要。安全有效地處理高效化合物、生物製劑和複雜製造流程的需求推動了對先進生物安全櫃的需求不斷增長。

2024年6月，Pfizer宣佈大幅擴大在美國的疫苗生產設施，提高新疫苗和現有疫苗的產能。此次擴建包括安裝最先進的平衡計分卡，以確保符合嚴格的安全和品質要求。同樣，2024 年 4 月，美國食品藥物管理局 (FDA) 更新了生物製品製造指南，強調實驗室和製造環境中生物安全措施的重要性。這些進展突顯了平衡計分卡在滿足藥物和疫苗研究日益增長的需求方面的關鍵作用，從而促使市場擴張，以滿足不斷變化的行業需求。

先進型號的高成本會阻礙生物安全櫃市場的成長嗎？

先進生物安全櫃 (BSC) 的高成本可能會阻礙市場成長，特別是對於預算有限的小型實驗室和研究設施。這些先進型號配備了尖端的安全功能和技術，由於其時尚的設計、高品質的材料和嚴格的製造標準，價格昂貴。獲取和維護此類設備的成本可能是一個重大障礙，限制了沒有資源投資此類高端模型的機構的使用。這一成本因素可能導致一些機構推遲或放棄升級，進而影響整體市場成長。

此外，先進平衡計分卡所需的高初始投資可能會阻止新進入者進入研究和生物技術行業，從而減緩市場成長。規模較小的新興實驗室可能會選擇更便宜、規格較低的型號來控制預算，從而影響尖端安全技術的採用率。因此，雖然對高效能 BSC 的需求不斷增加，但這些先進模型的高昂成本構成了限制市場成長和尖端安全解決方案廣泛採用的課題。

The growing emphasis on laboratory safety, as well as the strict regulations that govern research and clinical settings. With the increase in biopharmaceutical research, particularly in drug development, vaccine production, and advanced therapies, there is a greater demand for controlled environments that protect both personnel and research materials from contamination. The ongoing expansion of healthcare infrastructure, particularly in emerging markets, is also helping to drive market growth as more laboratories and healthcare facilities are built boosting the market growth surpassing USD 204.96 Million in 2024 and reachingUSD 328.5 Million by 2031.

Additionally, the COVID-19 pandemic has highlighted the importance of biosafety, resulting in increased investments in high-quality safety cabinets to ensure pathogen containment and adherence to safety protocols. As a result, these critical factors are expected to propel the market higher is expected to grow at aCAGR of about 6.70% from 2024 to 2031.

Biological Safety Cabinets Market: Definition/ Overview

Biological safety cabinets (BSCs) are enclosed, ventilated laboratory spaces intended to protect the user, the environment, and the research materials from harmful pathogens and contaminants. They are commonly used in microbiology, virology, biopharmaceutical research, and clinical diagnostics, all of which require the handling of infectious or hazardous materials. The future of BSCs looks promising, with growing adoption driven by the expanding biopharmaceutical industry, increased emphasis on laboratory safety, and rising regulatory standards around the world. As biotechnology and healthcare advance, the demand for more advanced and customized BSCs is expected to rise, particularly with the incorporation of smart technologies to improve safety and efficiency.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Increasing Advancement in Drug Development and Vaccine Production Propel the Biological Safety Cabinets Market?

Increasing advancements in drug development and vaccine production are expected to significantly boost the market for biological safety cabinets (BSCs). As the pharmaceutical industry develops new drug therapies and vaccine technologies, there is an increasing demand for high-quality BSCs to provide a sterile and safe environment for research and production processes. The complexity and scale of modern drug development and vaccine production necessitate advanced BSCs to protect both researchers and products from contamination, making these cabinets critical for maintaining rigorous safety standards in laboratories. The increased demand for sophisticated BSCs stems from the need to safely and effectively handle high-potency compounds, biological agents, and complex manufacturing processes.

In June 2024, Pfizer announced a significant expansion of its vaccine production facilities in the United States to increase capacity for new and existing vaccines. This expansion includes the installation of cutting-edge BSCs to ensure compliance with stringent safety and quality requirements. Similarly, in April 2024, the United States Food and Drug Administration (FDA) issued updated guidelines for biologic production, emphasizing the importance of improved biosafety measures in laboratories and production environments. These advancements highlight the critical role of BSCs in meeting the growing demands of drug and vaccine research, resulting in market expansion in response to changing industry needs.

Will High Cost of Advanced Models Hinder the Growth of the Biological Safety Cabinets Market?

The high cost of advanced biological safety cabinets (BSCs) can impede market growth, particularly for smaller laboratories or research facilities with limited budgets. These advanced models, which are frequently outfitted with cutting-edge safety features and technologies, command a high price due to their sophisticated design, high-quality materials, and stringent manufacturing standards. The cost of acquiring and maintaining such equipment can be a significant barrier, potentially limiting access for institutions without the resources to invest in these high-end models. This cost factor may cause some organizations to delay or forego upgrades, affecting overall market growth.

Furthermore, the high initial investment required for advanced BSCs may deter new entrants into the research and biotechnology industries, slowing market growth. Smaller and emerging laboratories may choose less expensive, lower-specification models to manage their budgets, affecting the adoption rate of cutting-edge safety technologies. As a result, while demand for high-performance BSCs continues to rise, the prohibitively expensive nature of these advanced models poses a challenge that may limit market growth and the widespread adoption of cutting-edge safety solutions.

Category-Wise Acumens

Will Rising Usage of Class II Drive the Biological Safety Cabinets Market?

The increasing use of Class II biological safety cabinets (BSCs) is expected to fuel significant growth in the biological safety cabinets market. Class II BSCs are widely used because they provide balanced protection for both the user and the environment, making them ideal for handling a wide range of biological agents in research and clinical settings. Their versatility and effectiveness in maintaining a sterile working environment make them the preferred choice for microbiology, pharmaceutical, and clinical diagnostic laboratories. As the demand for these applications grows, so does the demand for Class II BSCs, which contributes to their expanding market presence.

Furthermore, in July 2024, the US National Institutes of Health (NIH) updated its guidelines to emphasize the use of Class II BSCs in dealing with a broader range of infectious agents, accelerating their adoption in research facilities. These factors demonstrate how the increasing use of Class II BSCs is driving market growth while reinforcing their critical role in laboratory safety.

However, Class III Biological Safety Cabinets are the fastest growing segment. These cabinets, designed for handling highly infectious or hazardous materials, offer the highest level of protection and are becoming increasingly popular in specialized research settings and high-security laboratories. As demand for advanced containment solutions in biopharmaceutical and high-risk research fields grows, so does the Class III segment. This trend is being driven by increased investments in pathogenic organism research and the need for improved safety measures, with Class III BSCs emerging as the market's fastest-growing segment.

Will Rising Sales through Pharmaceutical, Biotechnology Companies Fuel the Biological Safety Cabinets Market?

Rising sales from pharmaceutical and biotechnology companies are expected to significantly boost the biological safety cabinets (BSCs) market. These companies are at the forefront of drug development, vaccine research, and biotechnological advancements, all of which necessitate stringent safety protocols to handle hazardous materials while protecting both researchers and products. As these industries expand their research and production capabilities, they invest more in advanced BSCs to meet regulatory requirements and maintain a sterile working environment. The growing emphasis on innovation and the development of new therapies increases demand for high-quality safety cabinets, which are critical for maintaining compliance with safety standards in these high-risk environments.

In July 2024, Johnson & Johnson announced a significant expansion of its research and development facilities to accelerate vaccine and therapeutic research. This expansion includes a significant investment in cutting-edge BSCs to ensure the safety and efficacy of its research procedures. Similarly, in June 2024, Amgen announced plans to upgrade its laboratory infrastructure with advanced BSCs as part of its commitment to improving research capabilities and meeting changing safety standards. These investments by major pharmaceutical and biotechnology companies demonstrate how rising sales and growth in these industries are driving demand for biological safety cabinets, thereby contributing to the market's overall expansion.

On the other hand, research laboratories and academic institutions are the fastest growing segment. This expansion is being driven by increased investments in research activities, emerging academic research initiatives, and the expansion of research facilities. The demand for advanced safety equipment is rapidly increasing due to the need to comply with stringent research standards and support various scientific studies. As academic and research institutions expand their capabilities and focus on cutting-edge research, the demand for biological safety cabinets is expected to grow the fastest.

Country/Region-wise

Will Growing Stringent Safety Regulations in North America Drive the Biological Safety Cabinets Market?

Growing stringent safety regulations in North America are a major driver of the biological safety cabinet (BSC) market. The region is well-known for its stringent laboratory safety regulations, particularly when dealing with infectious agents and hazardous materials. These regulations, enforced by organizations such as the Occupational Safety and Health Administration (OSHA) and the Centers for Disease Control and Prevention (CDC) in the United States, require the use of BSCs in a variety of research and clinical settings to protect both personnel and the environment from potential contamination. As research into infectious diseases, biopharmaceuticals, and advanced therapies expands, so does the demand for compliant, high-performance BSCs. This regulatory pressure ensures that laboratories and healthcare facilities regularly upgrade their equipment to meet the most recent safety standards thereby driving market growth in the region and enabling the region witness rapid growth.

In June 2024, the CDC updated its laboratory biosafety guidelines, emphasizing the need for more advanced BSCs with improved containment capabilities, particularly in facilities conducting research on highly pathogenic organisms. This update has prompted laboratories throughout North America to invest in newer, more sophisticated BSCs to ensure compliance. In March 2024, Labconco Corporation, a leading BSC manufacturer in the United States, announced the launch of a new line of BSCs designed to meet the most recent regulatory requirements while also providing superior protection. These developments demonstrate how stringent safety regulations not only ensure a safe research environment, but also drive demand for cutting-edge BSCs, resulting in market growth in North America.

Will Increasing Investments in Biotechnology Research in Asia-Pacific Propel the Biological Safety Cabinets Market?

Increasing investments in biotechnology research in Asia-Pacific are expected to drive the region's biological safety cabinets (BSCs) market. Asia-Pacific is emerging as a major hub for biotechnology and pharmaceutical research, with China, India, and South Korea leading the way. These countries are seeing significant government and private sector investments aimed at expanding research capabilities, encouraging innovation, and improving healthcare infrastructure. This surge in biotechnology research necessitates the use of advanced BSCs to ensure researcher safety and experiment integrity, particularly in areas such as drug discovery, vaccine development, and genetic research.

In July 2024, the Chinese government announced a major investment initiative to boost the biotechnology sector, which included the construction of new research facilities and laboratories. This initiative is part of China's larger strategy to become a global leader in biotech innovation, and it is expected to boost demand for BSCs in the country. Additionally, in May 2024, Thermo Fisher Scientific, a leading global supplier of scientific equipment, increased its manufacturing capacity in Asia-Pacific, specifically to meet the region's growing demand for BSCs. These investments by both governments and businesses highlight the critical role that BSCs play in ensuring the safety of cutting-edge research, as well as the market's strong growth potential in Asia-Pacific.

Competitive Landscape

The competitive landscape of the biological safety cabinets market is characterized by a mix of established and emerging players, with increasing competition driven by technological advancements and the rising focus on safety standards in laboratories. Smaller companies and new entrants are gaining traction by offering cost-effective and innovative solutions, often targeting niche markets or regions with specific regulatory requirements. Additionally, partnerships, mergers, and acquisitions are common strategies among these players to expand their market presence and enhance their product portfolios. The market is also seeing a growing trend toward customization and the integration of smart technologies, as companies strive to differentiate their offerings and meet the evolving needs of end-users.

Some of the prominent players operating in the biological safety cabinets market include:

Esco Micro

Labconco

The Baker Company

Kewaunee Scientific

NuAire

Germfree Laboratories

Cruma

Air Science

BIOBASE

Azbil Telstar

Latest Developments

In May 2024, The Baker Company introduced a new Class III biological safety cabinet with improved ergonomic features and enhanced containment capabilities for handling high-risk pathogens, addressing the growing safety needs in high-security labs.

In February 2024, VWR International introduced a new Class II BSC with a modular design for easy customization and scalability, aimed at meeting the diverse needs of various research and clinical environments.

In March 2024,Beckman Coulter introduced a cutting-edge Class II biological safety cabinet complete with advanced real-time monitoring and alarm systems that provide immediate alerts to any deviations from safety protocols.